Penobscot Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $352K | Hold |
|
|||||
|
2025
Q1 | $425K | Hold |
|
|||||
|
2024
Q4 | $477K | Hold |
|
|||||
|
2024
Q3 | $704K | Hold |
|
|||||
|
2024
Q2 | $704K | Hold |
|
|||||
|
2024
Q1 | $645K | Sell |
|
|||||
|
2023
Q4 | $592K | Hold |
|
|||||
|
2023
Q3 | $555K | Hold |
|
|||||
|
2023
Q2 | $484K | Hold |
|
|||||
|
2023
Q1 | $554K | Sell |
|
|||||
|
2022
Q4 | $757K | Hold |
|
|||||
|
2022
Q3 | $723K | Hold |
|
|||||
|
2022
Q2 | $620K | Hold |
|
|||||
|
2022
Q1 | $733K | Hold |
|
|||||
|
2021
Q4 | $662K | Buy |
|
|||||
|
2021
Q3 | $560K | Hold |
|
|||||
|
2021
Q2 | $517K | Buy |
|
|||||
|
2021
Q1 | $319K | Hold |
|
|||||
|
2020
Q4 | $326K | Hold |
|
|||||
|
2020
Q3 | $378K | Sell |
|
|||||
|
2020
Q2 | $499K | Hold |
|
|||||
|
2020
Q1 | $391K | Hold |
|
|||||
|
2019
Q4 | $300K | Hold |
|
|||||
|
2019
Q3 | $222K | Hold |
|
|||||
|
2019
Q2 | $250K | Hold |
|
|||||
|
2019
Q1 | $328K | Hold |
|
|||||
|
2018
Q4 | $299K | Buy |
|
|||||
|
2018
Q3 | $283K | Hold |
|
|||||
|
2018
Q2 | $241K | Hold |
|
|||||
|
2018
Q1 | $241K | Hold |
|
|||||
|
2017
Q4 | $263K | Hold |
|
|||||
|
2017
Q3 | $313K | Hold |
|
|||||
|
2017
Q2 | $344K | Hold |
|
|||||
|
2017
Q1 | $271K | Hold |
|
|||||
|
2016
Q4 | $257K | Hold |
|
|||||
|
2016
Q3 | $281K | Hold |
|
|||||
|
2016
Q2 | $244K | Hold |
|
|||||
|
2016
Q1 | $252K | Hold |
|
|||||
|
2015
Q4 | $380K | Hold |
|
|||||
|
2015
Q3 | $326K | Hold |
|
|||||
|
2015
Q2 | $357K | Hold |
|
|||||
|
2015
Q1 | $316K | Hold |
|
|||||
|
2014
Q4 | $287K | Hold |
|
|||||
|
2014
Q3 | $252K | Buy |
|